Related Experiment Video
Updated: Jun 9, 2025
The Establishment of a Murine Mandibular Molar Extraction Socket Healing Model
Published on: January 13, 2023
The Clinical Efficacy and Safety of ErhBMP-2/BioCaP/β-TCP as a Novel Bone Substitute Using the
Lingfei Wei1,2,3, Yuanyuan Sun1,2, Dedong Yu1
1Department of Second Dental Center, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.
This study shows that ErhBMP-2/BioCaP/β-TCP is a safe and effective bone substitute, significantly increasing new bone density and reducing augmentation needs in dental implant patients.
Area of Science:
- Biomaterials science
- Regenerative medicine
- Oral surgery
Background:
- Bone regeneration is crucial for dental implant success.
- Current bone substitutes have limitations.
- Escherichia coli-derived recombinant human bone morphogenetic protein 2 (ErhBMP-2) shows promise for bone healing.
Purpose of the Study:
- To evaluate the efficacy and safety of ErhBMP-2/BioCaP/β-TCP as a novel bone substitute.
- To compare ErhBMP-2/BioCaP/β-TCP with β-TCP alone and natural healing in a tooth extraction socket model.
Main Methods:
- A randomized controlled trial involving 40 patients undergoing single-root tooth extraction for dental implants.
- Patients were assigned to ErhBMP-2/BioCaP/β-TCP, β-TCP, or natural healing groups.
- Histomorphometric analysis of new bone volume density was performed at 6 weeks post-operatively.
Main Results:
- The ErhBMP-2/BioCaP/β-TCP group showed significantly higher new bone volume density compared to the β-TCP group.
- Fewer bone augmentation procedures were needed in the ErhBMP-2/BioCaP/β-TCP group compared to natural healing.
- No significant differences in safety parameters were observed among the groups.
Conclusions:
- ErhBMP-2/BioCaP/β-TCP is a safe and effective bone substitute for dental applications.
- This novel biomaterial promotes enhanced bone regeneration.
- Further clinical studies are warranted to explore its full potential.
